WNT inhibition creates a BRCA‐like state in Wnt‐addicted cancer
Open Access
- 4 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 13 (4), e13349
- https://doi.org/10.15252/emmm.202013349
Abstract
Wnt signaling maintains diverse adult stem cell compartments and is implicated in chemotherapy resistance in cancer. PORCN inhibitors that block Wnt secretion have proven effective in Wnt‐addicted preclinical cancer models and are in clinical trials. In a survey for potential combination therapies, we found that Wnt inhibition synergizes with the PARP inhibitor olaparib in Wnt‐addicted cancers. Mechanistically, we find that multiple genes in the homologous recombination and Fanconi anemia repair pathways, including BRCA1, FANCD2, and RAD51, are dependent on Wnt/β‐catenin signaling in Wnt‐high cancers, and treatment with a PORCN inhibitor creates a BRCA‐like state. This coherent regulation of DNA repair genes occurs in part via a Wnt/β‐catenin/MYBL2 axis. Importantly, this pathway also functions in intestinal crypts, where high expression of BRCA and Fanconi anemia genes is seen in intestinal stem cells, with further upregulation in Wnt‐high APCmin mutant polyps. Our findings suggest a general paradigm that Wnt/β‐catenin signaling enhances DNA repair in stem cells and cancers to maintain genomic integrity. Conversely, interventions that block Wnt signaling may sensitize cancers to radiation and other DNA damaging agents.Funding Information
- National Medical Research Council (NMRC/STAR/0017/2013, NMRC/OFIRG/0055/2017)
This publication has 98 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Recurrent R-spondin fusions in colon cancerNature, 2012
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16BNature Medicine, 2012
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsProceedings of the National Academy of Sciences of the United States of America, 2012
- Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathwaysProceedings of the National Academy of Sciences of the United States of America, 2011
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- miR-29 and miR-30 regulate B-Myb expression during cellular senescenceProceedings of the National Academy of Sciences of the United States of America, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriersMolecular Cancer Therapeutics, 2009
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007